Compare SDGR & MFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SDGR | MFIC |
|---|---|---|
| Founded | 1990 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 925.8M | 907.7M |
| IPO Year | 2020 | N/A |
| Metric | SDGR | MFIC |
|---|---|---|
| Price | $12.15 | $10.77 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | ★ $21.00 | $11.25 |
| AVG Volume (30 Days) | ★ 1.3M | 566.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.84% |
| EPS Growth | ★ 45.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $255,869,000.00 | N/A |
| Revenue This Year | $0.76 | N/A |
| Revenue Next Year | $4.60 | N/A |
| P/E Ratio | ★ N/A | $10.50 |
| Revenue Growth | ★ 23.29 | N/A |
| 52 Week Low | $10.95 | $9.48 |
| 52 Week High | $27.63 | $13.51 |
| Indicator | SDGR | MFIC |
|---|---|---|
| Relative Strength Index (RSI) | 47.21 | 35.01 |
| Support Level | $11.18 | $10.01 |
| Resistance Level | $13.36 | $11.81 |
| Average True Range (ATR) | 0.65 | 0.30 |
| MACD | -0.06 | -0.13 |
| Stochastic Oscillator | 32.53 | 1.67 |
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. The investment objective of the company is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.